Clinical Trial Update: Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA System [NA]

View source ↗

Summary

A clinical trial update indicates that the FARAPULSE pulsed-field ablation system from Boston Scientific is evaluating novel waveforms for atrial fibrillation a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• FARAPULSE PFA System

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation | NA | Status: RECRUITING